The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women
Abstract
BACKGROUND: While high-sensitivity C-reactive protein (hsCRP) is an independent predictor of cardiovascular risk, global risk prediction models incorporating hsCRP have not been developed for clinical use. OBJECTIVE: To develop and compare global cardiovascular risk prediction models with and without hsCRP. DESIGN: Observational cohort study. SETTING: U.S. female health professionals. PARTICIPANTS: Initially healthy nondiabetic women age 45 years and older participating in the Women's Health Study and followed an average of 10 years. MEASUREMENTS: Incident cardiovascular events (myocardial infarction, stroke, coronary revascularization, and cardiovascular death). RESULTS: High-sensitivity CRP made a relative contribution to global risk at least as large as that provided by total, high-density lipoprotein (HDL), and low-density lipoprotein (LDL) cholesterol individually, but less than that provided by age, smoking, and blood pressure. All global measures of fit improved when hsCRP was included, with likelihood-based measures demonstrating strong preference for models that include hsCRP. With use of 10-year risk categories of 0% to less than 5%, 5% to less than 10%, 10% to less than 20%, and 20% or greater, risk prediction was more accurate in models that included hsCRP, particularly for risk between 5% and 20%. Among women initially classified with risks of 5% to less than 10% and 10% to less than 20% according to the Adult Treatment Panel III covariables, 21% and 19%, respectively, were reclassified into more accurate risk categories. Although addition of hsCRP had minimal effect on the c-statistic (a measure of model discrimination) once age, smoking, and blood pressure were accounted for, the effect was nonetheless greater than that of total, LDL, or HDL cholesterol, suggesting that the c-statistic may be insensitive in evaluating risk prediction models. LIMITATIONS: Data were available only for women. CONCLUSIONS: A global risk prediction model that includes hsCRP improves cardiovascular risk classification in women, particularly among those with a 10-year risk of 5% to 20%. In models that include age, blood pressure, and smoking status, hsCRP improves prediction at least as much as do lipid measures.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CRP has emerged as a particularly stronger independent risk factor for cardiovascular disease than the low-density lipoprotein cholesterol level [13, 33, 34].”
From Exercise as a Mean to Control Low‐Grade Systemic Inflammation (2008) · cites this paper as [33]
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
The Elements of Statistical Learning
Hastie, T., Tibshirani, R., & Friedman, J. (2009) · Springer Series in Statistics · doi:10.1007/978-0-387-84858-7 · Cited by 25,970
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Harrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Research works printed but not linked: 3
- Buring JE, 1992, Journal of Myocardial Ischemia, 4, 27
- Nagelkerke NJ, 1991, Biomka, 78, 691
- Boekholdt SM, 2005, Atherosclerosis
Cited by
Sorted by citations
Items 201–300 of 503
Multiple Biomarkers for Predicting Cardiovascular Events
Wang, T. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.019 · Cited by 39
Inflammation and Oral Contraceptive Use in Female Athletes Before the Rio Olympic Games
Larsen, B., Cox, A., Colbey, C., Drew, M., McGuire, H., Fazekas de St Groth, B., Hughes, D., Vlahovich, N., Waddington, G., Burke, L., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00497 · Cited by 38
“L−1 (“very high” CVD risk) (Cook et al., 2006; Cauci et al., 2017), whereas two OC users (8%) fell into this category in the current cohort.”
BackgroundMethodSleutjes, J. A. M., van der Woude, C. J., Verploegh, P. J. P., Aribas, E., Kavousi, M., van Lennep, J. E. R., & de Vries, A. C. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad124 · Cited by 37
Arvanitakis, K., Koufakis, T., Popovic, D. S., Maltese, G., Mustafa, O. G., Doumas, M. N., Γιουλεμέ, Ό., Kotsa, K., & Germanidis, G. S. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00506-3 · Cited by 39
Major Depression, C-Reactive Protein, and Incident Ischemic Heart Disease in Healthy Men and Women
Surtees, P. G., Wainwright, N. W. J., Boekholdt, S. M., Luben, R., Wareham, N. J., & Khaw, K. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318183acd5 · Cited by 36
N-Glycosylation Profiles of Immunoglobulin G and Future Cardiovascular Events
Hoshi, R. A., Plavša, B., Liu, Y., Trbojević‐Akmačić, I., Glynn, R. J., Ridker, P. M., Cummings, R. D., Gudelj, I., Lauc, G., Demler, O., et al. (2024) · Circulation Research · doi:10.1161/circresaha.123.323623 · Cited by 37
Simplifying cardiovascular risk estimation using resting heart rate
Cooney, M. T., Vartiainen, E. A., Laatikainen, T. K., Joulevi, A., Dudina, A. L., & Graham, I. M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq164 · Cited by 36
Grootendorst, D. C., de Jager, D. J., Brandenburg, V. M., Boeschoten, E. W., Krediet, R. T., Dekker, F. W., & The NECOSAD Study Group (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm381 · Cited by 35
Antipsychotics and Metabolics in the Post-CATIE Era
Meyer, J. M. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_45 · Cited by 36
Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease
Elliott, P. (2009) · JAMA · doi:10.1001/jama.2009.954 · Cited by 35
Liman, T., Zietemann, V., Wiedmann, S., Jungehuelsing, G. J., Endres, M., Wollenweber, F. A., Wellwood, I., Dichgans, M., & Heuschmann, P. U. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00871.x · Cited by 32
Cardiovascular Risk Assessment
Pletcher, M. J., & Moran, A. E. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.03.002 · Cited by 42
A predictive model of progressive chronic kidney disease in idiopathic nephrotic syndrome
Mendonça, A. C. Q., OLIVEIRA, E. A., Fróes, B. P. E., Faria, L. D. D. C., Pinto, J. S., Nogueira, M. M. I., Lima, G. O., Resende, P. I., Assis, N. S., Silva, A. C. S. E., et al. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3136-0 · Cited by 35
Statin Therapy in Rheumatoid Arthritis
Bansback, N. J., Ara, R., Ward, S. E., Anis, A. H., & Choi, H. K. (2009) · PharmacoEconomics · doi:10.2165/00019053-200927010-00004 · Cited by 34
Soriano‐Maldonado, A., Aparicio, V. A., Félix-Redondo, F. J., & Fernandez-Berges, D. J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.253 · Cited by 35
Lewis, J. R., Lim, W. H., Dhaliwal, S. S., Zhu, K., Lim, E. M., Thompson, P. L., & Prince, R. L. (2012) · BMC Nephrology · doi:10.1186/1471-2369-13-58 · Cited by 34
Use of Obesity Biomarkers in Cardiovascular Epidemiology
Pischon, T. (2009) · Disease Markers · doi:10.1155/2009/757683 · Cited by 34
Cardiovascular Risk Factors in the Elderly
Melek, Z. (2012) · InTech eBooks · doi:10.5772/32362 · Cited by 34
New cardiovascular risk determinants do exist and are clinically useful
Smulders, Y. M., Thijs, A., & Twisk, J. W. R. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehm566 · Cited by 34
Further Improvements in CHD Risk Prediction for Women
Blumenthal, R. S., Michos, E. D., & Nasir, K. (2007) · JAMA · doi:10.1001/jama.297.6.641 · Cited by 33
Roos, C. J., Quax, P. H. A., & Jukema, J. W. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.11.105 · Cited by 30
Plasma CRP Levels in Premenopausal Women with Major Depression: A 12-Month Controlled Study
Cizza, G., Eskandari, F., Coyle, M., Krishnamurthy, P., Wright, E. C., Mistry, S., & Csákó, G. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0029-1220717 · Cited by 32
Verwoert, G. C., Elias‐Smale, S. E., Rizopoulos, D., Koller, M. T., Steyerberg, E. W., Albert Hofman, D., Kavousi, M., Sijbrands, E. J. G., Hoeks, A. P. G., Reneman, R. S., et al. (2011) · Journal of Human Hypertension · doi:10.1038/jhh.2010.124 · Cited by 32
Vittinghoff, E., Glidden, D. V., SHIBOSKI, S. C., & McCulloch, C. E. (2012) · Statistics in the health sciences · doi:10.1007/978-1-4614-1353-0_10 · Cited by 31
Lp-PLA2: A New Target for Statin Therapy
Braun, L. T., & Davidson, M. H. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0074-y · Cited by 31
Economic Evaluations in Rheumatoid Arthritis
Bansback, N. J., Ara, R., Karnon, J. D., & Anis, A. H. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826050-00004 · Cited by 31
Ito, H., Pacold, I. V., Durazo-Arvizú, R., Liu, K., Shilipak, M. G., Goff, D. C., Tracy, R. P., & Kramer, H. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr185 · Cited by 30
Cardiovascular implications of inflammatory bowel disease: An updated review
Bhardwaj, A., Singh, A., Midha, V., Sood, A., Wander, G. S., Mohan, B., & Batta, A. (2023) · World Journal of Cardiology · doi:10.4330/wjc.v15.i11.553 · Cited by 30
May, A., & Wang, T. J. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.6.793 · Cited by 31
Ohsawa, M., Tanno, K., Itai, K., Turin, T. C., Okamura, T., Ogawa, A., Ogasawara, K., Fujioka, T., Onoda, T., Yoshida, Y., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-12-0982 · Cited by 30
Qureshi, W., Rana, J. S., Yeboah, J., Nasir, U., & Al-Mallah, M. H. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0666-9 · Cited by 30
Steyerberg, E. W., Vedder, M. M., Leening, M. J. G., Postmus, D., D’Agostino, R. B., CALSTER, B. V., & Pencina, M. J. (2014) · Biometrical Journal · doi:10.1002/bimj.201300260 · Cited by 29
Bushnell, G., Stürmer, T., White, A., Pate, V., Swanson, S. A., Azrael, D. R., & Miller, M. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.012 · Cited by 29
Clinical risk reclassification at 10 years
Cook, N. R., Demler, O., & Paynter, N. P. (2017) · Statistics in Medicine · doi:10.1002/sim.7340 · Cited by 29
Sniderman, A. D., Holme, I., AASTVEIT, A. H., Furberg, C. D., Walldius, G., & Jungner, I. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.02.086 · Cited by 29
Miladinović, B., Kumar, A., Mhaskar, R. S., Kim, S., Schonwetter, R. S., & Djulbegović, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047804 · Cited by 29
Arsenault, B. J., Pîbarot, P., & Després, J. (2008) · Cardiology · doi:10.1159/000165919 · Cited by 28
Assessing the incremental predictive performance of novel biomarkers over standard predictors
Xanthakis, V., SULLIVAN, L. M., Vasan, R. S., Benjamin, E. J., Massaro, J. M., D’Agostino, R. B., & Pencina, M. J. (2014) · Statistics in Medicine · doi:10.1002/sim.6165 · Cited by 28
Cook, N. R., Paynter, N. P., Manson, J. E., Martin, L. W., Robinson, J. G., Wassertheil-Smoller, S. W., & Ridker, P. M. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.188870 · Cited by 28
Chong, J. J. H., Prince, R. L., Thompson, P. L., Thavapalachandran, S., Ooi, E. M. M., Devine, A., Lim, E. E. M., Byrnes, E., Wong, G., Lim, W. H., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.011028 · Cited by 29
McCormack, J. P., & Allan, G. M. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000196 · Cited by 28
Horn, C. S., Ilg, R., Sander, K., Bickel, H., Briesenick, C., Hemmer, B., Poppert, H., & Sander, D. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5017-6 · Cited by 27
Hormonal and Nutritional Effects on Cardiovascular Risk Markers in Young Women
Lawson, E. A., Miller, K. K., Mathur, V. A., Misra, M., Meenaghan, E. M., Herzog, D. B., & Klibanski, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0364 · Cited by 27
C-reactive protein and cardiovascular risk: more fuel to the fire
Boekholdt, S. M., & Kastelein, J. J. P. (2009) · The Lancet · doi:10.1016/s0140-6736(09)62098-5 · Cited by 27
Quinn, K., Cox, A. J., Roberts, L. A., Pennell, E. N., McKeating, D. R., Fisher, J. J., Perkins, A. V., & MINAHAN, C. L. (2021) · European Journal of Applied Physiology · doi:10.1007/s00421-021-04734-0 · Cited by 26
Wei, M., Xiong, P., Zhang, L., Fei, M., Chen, A., & Li, F. (2013) · 中医杂志:英文版 · doi:10.1016/s0254-6272(13)60120-x · Cited by 26
Challenges to Improve Coronary Heart Disease Risk Assessment
Wilson, P. W. F. (2009) · JAMA · doi:10.1001/jama.2009.1765 · Cited by 26
Schetinin, V., Jakaite, L., & Krzanowski, W. J. (2018) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2018.01.009 · Cited by 27
Stamatelopoulos, K., Mueller‐Hennessen, M., Georgiopoulos, G. A., López‐Ayala, P., Sachse, M., Vlachogiannis, N. I., Sopova, K., Delialis, D., Bonini, F., Patras, R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.05.055 · Cited by 25
Oral postmenopausal hormone therapy, C-reactive protein, and cardiovascular outcomes
Kurtz, E. G., Ridker, P. M., Rose, L. M., Cook, N. R., Everett, B. M., Buring, J. E., & Rexrode, K. M. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181e750dd · Cited by 25
Bogavac‐Stanojević, N., Jelić‐Ivanović, Z., Spasojević‐Kalimanovska, V., Spasić, S., & Kalimanovska‐Oštrić, D. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.05.012 · Cited by 25
The 2006 William Feinberg Lecture
Sacco, R. L. (2007) · Stroke · doi:10.1161/strokeaha.106.481143 · Cited by 25
Zheng, Y., Parast, L. M., Cai, T., & Brown, M. (2012) · Lifetime Data Analysis · doi:10.1007/s10985-012-9239-z · Cited by 24
Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs
KONES, R. J., & Rumana, U. (2015) · Drugs · doi:10.1007/s40265-015-0429-3 · Cited by 26
Neopterin: An immune biomarker of coronary artery disease and its association with other CAD markers
Firoz, C. K., Jabir, N. R., Kamal, M. A., Alama, M. N., Damanhouri, G. A., Khan, W., Alzahrani, A. S., Almehdar, H. A., & Tabrez, S. S. M. (2015) · IUBMB Life · doi:10.1002/iub.1390 · Cited by 24
On oxidative status and cardiovascular risk in women: Keeping pink at heart
Vassalle, C. (2009) · World Journal of Cardiology · doi:10.4330/wjc.v1.i1.26 · Cited by 23
An overview of stress and immunity.
Groër, M., Meagher, M. W., & Kendall-Tackett, K. A. (2010) · American Psychological Association eBooks · doi:10.1037/12065-001 · Cited by 26
Biological Surrogates for Enhancing Cardiovascular Risk Prediction in Type 2 Diabetes Mellitus
Clair, L. S., & Ballantyne, C. M. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.008 · Cited by 24
Evaluating the Predictive Value of Biomarkers with Stratified Case‐Cohort Design
Liu, D., Cai, T., & Zheng, Y. (2012) · Biometrics · doi:10.1111/j.1541-0420.2012.01787.x · Cited by 24
Should We Measure C‐reactive Protein on Earth or Just on JUPITER?
Bajpai, A., Goyal, A., & Sperling, L. S. (2010) · Clinical Cardiology · doi:10.1002/clc.20681 · Cited by 25
Gender difference in long-term prognosis among patients with cardiovascular disease
van der Meer, M. G., Cramer, M. J., van der Graaf, Y., Doevendans, P. A., Nathoe, H. M., & (on behalf of the SMART study group) (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312460519 · Cited by 23
Effects of menopause and tibolone on different cardiovascular biomarkers in healthy women
Vassalle, C., Cicinelli, E., Lello, S., Mercuri, A., Battaglia, D. B. R., & Maffei, S. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.488770 · Cited by 23
Salim, A., Tai, E. S., Tan, V. Y., Welsh, A. H., Liew, R., Naidoo, N., Wu, Y., Yuan, J., Koh, W., & van Dam, R. M. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487315626547 · Cited by 23
Interleukin 6 polymorphism corresponds to the number of severely stenosed coronary arteries.
Myśliwska, J. M., Więckiewicz, J., Hak, Ł., Siebert, J., Rogowski, J. A., Szyndler, K., & Myśliwski, A. (2006) · PubMed · Cited by 23
Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO
Biswas, S., Tankhiwale, N., Blackford, A. L., Gutierrez‐Barrera, A. M., Ready, K. J., Lu, K., Amos, C. I., Parmigiani, G., & Arun, B. K. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-1958-z · Cited by 22
Lee, W., Peng, L., Chiou, S.-T., & Chen, L. (2017) · Scientific Reports · doi:10.1038/srep40427 · Cited by 22
Lipid Measures and Cardiovascular Disease Prediction
van Wijk, D. F., Stroes, E. S. G., & Kastelein, J. J. P. (2009) · Disease Markers · doi:10.1155/2009/143680 · Cited by 23
Gorodeski, E. Z., Ishwaran, H., Blackstone, E. H., & Lauer, M. S. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.04.015 · Cited by 22
Hatoum, I. J., Cook, N. R., Nelson, J. J., Rexrode, K. M., & Rimm, E. B. (2011) · American Heart Journal · doi:10.1016/j.ahj.2010.11.007 · Cited by 20
Schnell‐Inderst, P., Schwarzer, R., Göhler, A., Grandi, N. C., Grabein, K., Stollenwerk, B., Manne‐Goehler, J., Klauß, V., Siebert, U., & Wasem, J. (2010) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462309990870 · Cited by 21
Beckie, T. M., Beckstead, J. W., & Groer, M. E. (2011) · Biological Research For Nursing · doi:10.1177/1099800411403469 · Cited by 22
Risk Scores for Prediction of Coronary Heart Disease: An Update
Wilson, P. W. F. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.11.001 · Cited by 21
Paradoxical Association of C-Reactive Protein with Endothelial Function in Rheumatoid Arthritis
Holmes, M. V., Jiang, B., McNeill, K. L., Wong, M., Oakley, S. P., Kirkham, B. W., & Chowienczyk, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010242 · Cited by 22
Nezic, D. G., Spasic, T., Mićović, S., Kosevic, D., Petrovic, I. M., Lausević-Vuk, L., Unic-Stojanovic, D. R., & Borzanovic, M. D. (2015) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2015.11.011 · Cited by 21
Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the heart of the issue
Gabbiadini, R., Buono, A. D., Mastrorocco, E., Solitano, V., Repici, A., Spinelli, A., Condorelli, G., & Armuzzi, A. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1143293 · Cited by 21
Between risk charts and imaging: how should we stratify cardiovascular risk in clinical practice?
Mureddu, G. F., Brandimarte, F., Faggiano, P. M., Rigo, F., & Nixdorff, U. (2013) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jes297 · Cited by 20
Improving Mortality Prediction Using Biosocial Surveys
Goldman, N., Glei, D. A., Lin, Y., & Weinstein, M. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwn389 · Cited by 20
Survival Regression Modeling Strategies in CVD Prediction
Barkhordari, M., Padyab, M., Sardarinia, M., Hadaegh, F., Azizi, F., & Bozorgmanesh, M. (2016) · Intern J Endocrinol Metab · doi:10.5812/ijem.32156 · Cited by 19
Inflammatory bowel disease and the risk of cardiovascular diseases
Paulina Núñez, F., García, S. G., Quera, R., & Gomollón, F. (2021) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2021.02.003 · Cited by 19
“Mind the gap” acute coronary syndrome in women: A contemporary review of current clinical evidence
Davis, E., Gorog, D. A., Rihal, C. S., Prasad, A., & Srinivasan, M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.10.020 · Cited by 19
Vigna, L., Vassalle, C., Tirelli, A. S., Gori, F., Tomaino, L., Sabatino, L., & Bamonti, F. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2017-0072 · Cited by 19
The causal exposure model of vascular disease
Sniderman, A. D., Lawler, P. R., Williams, K., Thanassoulis, G., Graaf, J. D., & Furberg, C. D. (2011) · Clinical Science · doi:10.1042/cs20110449 · Cited by 19
Evaluating New Cardiovascular Risk Factors for Risk Stratification
Stern, R. H. (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.07814.x · Cited by 19
Do novel biomarkers add to existing scores of total cardiovascular risk?
Backer, G. D., Graham, I. M., & Cooney, M. T. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312448988 · Cited by 18
Type-2 diabetes and coronary heart disease: common physiopathology, viewed from autoimmunity
Onat, A., Dönmez, İ., Karadeniz, Y., Çakır, H., & Kaya, A. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.910114 · Cited by 18
Sexton, D. J., O’Kelly, P., Kennedy, C., Denton, M., de Freitas, D. G., Magee, C., O’Seaghdha, C. M., & Conlon, P. J. (2018) · Clinical Kidney Journal · doi:10.1093/ckj/sfy130 · Cited by 18
La enfermedad inflamatoria intestinal y los riesgos de enfermedad cardiovascular
Paulina Núñez, F., García, S. G., Quera, R., & Gomollón, F. (2020) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2020.09.002 · Cited by 17
Faye, A. S., Axelrad, J. E., Sun, J., Halfvarson, J., Söderling, J. K., Olén, O., & Ludvigsson, J. F. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002502 · Cited by 17
Surrogate endpoints and emerging surrogate endpoints for risk reduction of cardiovascular disease
Rasnake, C. M., Trumbo, P. R., & Heinonen, T. M. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.00010.x · Cited by 16
Nonparametric Evaluation of Biomarker Accuracy Under Nested Case-Control Studies
Cai, T., & Zheng, Y. (2011) · Journal of the American Statistical Association · doi:10.1198/jasa.2011.tm09807 · Cited by 17
Preventing Cardiovascular Disease in Women: An Update
WENGER, N. K. (2007) · Clinical Cardiology · doi:10.1002/clc.20134 · Cited by 17
Onat, A., Can, G., Hergenç, G., Uğur, M., & Yüksel, H. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.10.010 · Cited by 17
Gender-Specific Prediction of Cardiac Disease
D'Amore, S., & Mora, S. (2006) · Cardiology in Review · doi:10.1097/01.crd.0000244460.25429.c8 · Cited by 17
Quirino, I. G., Dias, C. S., Vasconcelos, M. A., Poggiali, I. V., Gouvea, K. C., Pereira, A. K., Paulinelli, G. P., Moura, A. R., Ferreira, R., Colosimo, E. A., et al. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2870-z · Cited by 16
Cui, J. S., Forbes, A. B., Kirby, A. C., Simes, J. R., & Tonkin, A. M. (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32832f3b2b · Cited by 16
Circulating, Imaging, and Genetic Biomarkers in Cardiovascular Risk Prediction
Ge, Y., & Wang, T. J. (2011) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.03.007 · Cited by 16
Comparison of C-reactive protein levels in pregnancies with retained and removed intrauterine device
Deveer, R., Üstün, Y. E., Sarıkaya, E., Avşar, P. A., Doğanay, M., & Mollamahmutoğlu, L. (2011) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2010.545925 · Cited by 16
Stata Modules for Calculating Novel Predictive Performance Indices for Logistic Models
Barkhordari, M., Padyab, M., Hadaegh, F., Azizi, F., & Bozorgmanesh, M. (2016) · Intern J Endocrinol Metab · doi:10.5812/ijem.26707 · Cited by 15
Gender differences in vascular aging and in coronary artery disease pathophysiology
Blum, A. (2023) · QJM · doi:10.1093/qjmed/hcad027 · Cited by 15
The Role of Obesity in the Etiology and Carcinogenesis of Endometrial Cancer
Marin, A.-G., Filipescu, A. G., & Petca, A. T. (2024) · Cureus · doi:10.7759/cureus.59219 · Cited by 15
Metadata
- Authors
- Cook, N. R., Buring, J. E., & Ridker, P. M.
- Affiliations
- Brigham and Women's Hospital (US)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2006-07-04
- Volume
- 145
- Issue
- 1
- Pages
- 21-29
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2100083473
- Cited by
- 504
- References
- 50
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 8 · 2023: 10 · 2022: 9 · 2021: 11 · 2020: 7 · 2019: 13 · 2018: 14 · 2017: 9 · 2016: 19 · 2015: 23 · 2014: 21 · 2013: 31 · 2012: 35
- FWCI
- 58.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- UCLA - Biblioteca de Ciencias de la Salud (submittedVersion)
- Funders
- National Institutes of Health (5r01hl043851-10)
- National Heart, Lung, and Blood Institute (HL43851)
- National Cancer Institute (CA-47988, R01CA047988)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- high-sensitivity C-reactive protein, cardiovascular risk prediction, women, 10-year cardiovascular risk, risk reclassification, model discrimination, concordance index, myocardial infarction, stroke, cardiovascular mortality, Women's Health Study
- MeSH terms
- Age Factors, Blood Pressure, C-Reactive Protein, Cardiovascular Diseases, Female, Humans, Lipids, Middle Aged, Smoking, United States, Cohort Studies, Biomarkers, Proportional Hazards Models, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review